Displaying items by tag: Tetra Therapeutics

GRAND RAPIDS — Tetra Therapeutics Inc.’s sale to a Japanese pharmaceutical company provides a final pathway toward bringing to market potential new drugs to treat Alzheimer’s disease and a form of autism, as well as generates a handsome return for financial backers.

Published in Finance

GRAND RAPIDS — Drug developer Tetra Therapeutics Inc. has reached a definitive merger agreement with Japan-based pharmaceutical company Shionogi & Co. Ltd. in a deal that could reach $500 million.

Published in Health Care
Sunday, 15 March 2020 09:22

MiBiz Growth Report: March 15, 2020

MiBiz Growth Report for March 15, 2020.

Published in Economic Development

GRAND RAPIDS — Drug developer Tetra Therapeutics has secured a new equity investment from Japanese pharmaceutical company Shionogi & Co. Ltd.

Published in Health Care
Saturday, 28 September 2019 11:05

Growth Report: Sept. 28,2019

Growth report for Sept. 28, 2019.

Published in Economic Development

GRAND RAPIDS — Tetra Therapeutics says it is enrolling patients faster than expected for a clinical trial on a potential new drug to treat Alzheimer’s disease.

Published in Health Care